Grant: Discovery Grants Program - Individual
Carleton University
$24,000.00
Comprehensive studies of pharmaceutical aerosol generation and deposition in extra-thoracic (nose-mouth-throat) airways
EF 2011-12
Résumé
The research aims at the enhancement of both lung and nasal drug delivery by comprehensive experimental and numerical studies of pharmaceutical aerosol generation and deposition in devices and idealized replicas, some of which could be adopted as standards in the pharmaceutical field.
1) Aerosol Characterization of pMDIs (Pressurized Metered Dose Inhalers) with Add-on Spacers: Although pMDIs were developed in the 1950s, their relatively inefficient design remained basically the same throughout the years. If the medication losses per dosage can be reduced by using novel inhaler devices, there will be significant treatment enhancement with a reduction in side effects and improvement in patient's compliance. Deeper insight of the aerosol generation from commercial inhaler devices, and aerosol behaviour inside add-on devices, will be obtained using PDPA/LDV (Phase Doppler Particle Analyser / Laser Doppler Velocimetry).
2) Nasal Drug Delivery: Despite the growing interest, the pharmaceutical industry does not have a standard nasal replica for testing devices using aerosol medication. Most of the in-vitro studies that have appeared in the literature use realistic replicas of particular individuals, lacking universality when aerosol deposition is concerned. A novel and unique idealized nasal cavity geometry is under development, through comprehensive studies of nasal drug delivery systems, nasal geometries, nasal aerosol deposition, fluid flow measurements, and CFD (Computational Fluid Dynamics) simulations.
3) CFD Numerical Simulation (for Drug Delivery into either the Nose or Lungs): Although the simulation of particle deposition on adjacent walls from laminar flows is well understood, the same process in turbulent flows, which produces complex interactions between particles and near-wall turbulence, has not been accurately modelled and remains a challenging problem. Avoiding DNS (Direct Numerical Simulation) impractical computational costs, the use of two techniques, namely, Reynolds Averaged Navier-Stokes (RANS) equations and LES (Large Eddy Simulation) will be explored.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
312380-2010
Name nom
Matida, Edgar
Department département
Mechanical & Aerospace Engineering
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
24000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
5
Application title
Comprehensive studies of pharmaceutical aerosol generation and deposition in extra-thoracic (nose-mouth-throat) airways
Keyword
NSERC
Application summary
The research aims at the enhancement of both lung and nasal drug delivery by comprehensive experimental and numerical studies of pharmaceutical aerosol generation and deposition in devices and idealized replicas, some of which could be adopted as standards in the pharmaceutical field.
1) Aerosol Characterization of pMDIs (Pressurized Metered Dose Inhalers) with Add-on Spacers: Although pMDIs were developed in the 1950s, their relatively inefficient design remained basically the same throughout the years. If the medication losses per dosage can be reduced by using novel inhaler devices, there will be significant treatment enhancement with a reduction in side effects and improvement in patient's compliance. Deeper insight of the aerosol generation from commercial inhaler devices, and aerosol behaviour inside add-on devices, will be obtained using PDPA/LDV (Phase Doppler Particle Analyser / Laser Doppler Velocimetry).
2) Nasal Drug Delivery: Despite the growing interest, the pharmaceutical industry does not have a standard nasal replica for testing devices using aerosol medication. Most of the in-vitro studies that have appeared in the literature use realistic replicas of particular individuals, lacking universality when aerosol deposition is concerned. A novel and unique idealized nasal cavity geometry is under development, through comprehensive studies of nasal drug delivery systems, nasal geometries, nasal aerosol deposition, fluid flow measurements, and CFD (Computational Fluid Dynamics) simulations.
3) CFD Numerical Simulation (for Drug Delivery into either the Nose or Lungs): Although the simulation of particle deposition on adjacent walls from laminar flows is well understood, the same process in turbulent flows, which produces complex interactions between particles and near-wall turbulence, has not been accurately modelled and remains a challenging problem. Avoiding DNS (Direct Numerical Simulation) impractical computational costs, the use of two techniques, namely, Reynolds Averaged Navier-Stokes (RANS) equations and LES (Large Eddy Simulation) will be explored.